Deep learning analysis demonstrates high binary classification accuracy in breast cancer histopathology, highlighting automated screening potential amid pathologist shortages.
For women breast cancer is a life-threatening problem, making the importance of early detection crucial. Expert pathologists assess cell shapes in breast histopathology images at various magnification levels for accurate diagnosis. Unfortunately, a shortage of pathologists in many countries heightens the risk of human error in disease identification and treatment. To address this challenge, this study proposed a CBAM-Enhanced Collaborative Network for classifying benign and malignant tumors in breast cancer histopathological images, offering a potential solution to enhance accuracy and efficiency in diagnosis. The model included a transfer learning branch using a pretrained DenseNet121 structure with integrated CBAM (Convolutional Block Attention Module). Simultaneously, a collaborative branch employed Inception-ResNet-v2 with CBAM for feature extraction from histopathological images. The feature fusion module then optimized information from both branches. The proposed method achieved impressive binary classification accuracies on the BreaKHis dataset: 98.31% overall, with 98.33%, 98.08%, 99.67%, and 97.80% for magnification factors of 40x, 100x, 200x, and 400x, respectively. CBAM-Enhanced Collaborative Network also exhibits strong generalization capabilities, as evidenced by its superior performance on the ICIAR2018 BACH Challenge dataset.
No takes yet. Share an insight, caveat, or question.
Das et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: